Related Experiment Video
Updated: May 27, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
A prodrug approach to improve the physico-chemical properties and decrease the genotoxicity of nitro compounds
Man Chin Chung1, Priscila Longhin Bosquesi, Jean Leandro dos Santos
1Lapdesf- Laboratory of Drug Desing, Dept of Drugs and Medicines, School of Pharmaceutical Sciences, University of São Paulo State, Rodovia Araraquara- Jaú km1, cep 14802-901, Araraquara, SP, Brazil. chungmc@fcfar.unesp.br
Abstract:
In therapeutics research, the nitro compounds are part of an important group of drugs with multiple pharmacological activities. However, in drug design, the inclusion of a nitro group in a molecule changes the physico-chemical and electronic properties and is associated with increased mutagenicity and carcinogenicity. In addition, several studies have related the relationship between the antimicrobial and/or anti-protozoal activity and the mutagenic effect to reduction of the nitro group. This work reviews the toxicity of nitro compounds and shows how the use of prodrugs can increase the biological activity and decrease the genotoxicity of nitro compounds, without any modification in nitro reduction behavior, but rather by physico-chemical improvement. Examples are given of metronidazole and nitrofurazone prodrugs.
More Related Videos
Related Concept Videos
Prodrugs
Prodrugs help overcome...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Preparation of Amines: Reduction of Oximes and Nitro Compounds
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Phase I Reactions: Reductive Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Biotransformation: Overview

